Episurf Medical
1,23 SEK -3 %1 investor følger denne virksomhed
Episurf Medical is a medical technology company. The company conducts research and development of products used for the treatment of cartilage damage. Episurf's primary focus is on the recovery of knee joints, but the company's implants can also be applied to other joints. Episurf Medical is in the preclinical verification phase and is headquartered in Stockholm.
Omsætning
6,6 mio.
EBIT %
-1.166,67 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
EPIS B
Daglig lav / høj pris
1,23 / 1,268
SEK
Markedsværdi
327,71 mio. SEK
Aktieomsætning
46,37 t SEK
Volumen
37 t
Seneste videoer
Finanskalender
Delårsrapport
14.07.2023
Delårsrapport
27.10.2023
Årsrapport
09.02.2024
Viser Alle indholdstyper
